Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

5.9K
The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49).

European journal of cancer (Oxford, England : 1990)·2026
Same author

Bifunctional Photocatalysts: Exploiting Proximity for Enhanced Reaction Performance.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Dinutuximab beta effectively treats Ewing sarcoma when combined with chemotherapy.

iScience·2026
Same author

Intermittent fasting enhances cisplatin-metformin efficacy in therapy-resistant ovarian cancer PDXs.

iScience·2026
Same author

Impairment of oxidative metabolism compromises Rad51 recruitment and potentiates PARP inhibitor effectiveness in ovarian cancer.

Journal of experimental & clinical cancer research : CR·2026
Same author

Late-stage peptide modification with salicylaldehyde tag enhances affinity for nuclear factor-kappa B essential modulator.

RSC chemical biology·2025

Related Experiment Video

Updated: Jan 7, 2026

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
08:44

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Published on: July 30, 2020

5.2K

Pyrophosphate-modified liposomes for bone-targeted delivery.

Alberto Dal Corso1, Riccardo Becchetti2, Cristina Matteo2

  • 1Department of Chemistry, Università degli studi di Milano, Milan, Italy.

Journal of Liposome Research
|December 29, 2025
PubMed
Summary

Researchers developed Bone Binding Liposomes (BBL) for targeted bone disease treatment. These liposomes show enhanced bone mineral binding, improving drug delivery and reducing side effects for better bone cancer and disease therapies.

Keywords:
Liposomesbonemacrophagesresiquimodtargeted therapy

More Related Videos

Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes
11:31

Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes

Published on: February 18, 2020

8.2K
One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
09:51

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

Published on: September 17, 2013

11.2K

Related Experiment Videos

Last Updated: Jan 7, 2026

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
08:44

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Published on: July 30, 2020

5.2K
Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes
11:31

Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes

Published on: February 18, 2020

8.2K
One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
09:51

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

Published on: September 17, 2013

11.2K

Area of Science:

  • Biomaterials Science
  • Nanomedicine
  • Drug Delivery Systems

Background:

  • Bone-related diseases and cancers present significant treatment challenges.
  • Current therapies often lack specificity, leading to substantial off-target side effects.
  • There is a critical need for advanced drug delivery systems targeting bone tissue.

Purpose of the Study:

  • To develop and characterize a novel bone-targeted liposomal formulation.
  • To enhance drug delivery specifically to bone mineral (hydroxyapatite).
  • To evaluate the efficacy and safety profile of the targeted liposomes compared to non-targeted ones.

Main Methods:

  • Functionalization of liposomes with a pyrophosphate-cholesterol derivative to create Bone Binding Liposomes (BBL).
  • Comparative binding affinity studies of BBL versus conventional Non-Binding Liposomes (NBL) to hydroxyapatite.
  • Encapsulation of a prototype drug within both BBL and NBL formulations.
  • Assessment of drug-loaded liposome biocompatibility and preservation of drug properties on target cells (macrophages).

Main Results:

  • BBL demonstrated significantly superior binding affinity to bone mineral compared to NBL.
  • Both BBL and NBL formulations efficiently encapsulated the prototype drug.
  • Comparable biocompatibility was observed for both BBL and NBL.
  • The drug's physicochemical properties were preserved on macrophages when delivered via both liposomal formulations.

Conclusions:

  • Bone Binding Liposomes (BBL) represent a promising advancement in targeted drug delivery for bone conditions.
  • The pyrophosphate-cholesterol functionalization effectively enhances liposome affinity for bone mineral.
  • This targeted approach has the potential to improve therapeutic outcomes for bone diseases and cancers by increasing drug concentration at the target site and minimizing systemic toxicity.